Microvessel Origin and Distribution in Pulmonary Metastases of B16 Melanoma: Implication for Adoptive Immunotherapy

Cancer Research

Volumn 55, Issue 20, 1995, Pages 4627-4632

  Nannmark, Ulf ^a,b   Johansson, Bengt R ^a   Unger, Martin L ^a   Bryant, John L ^b,c   Goldfarb, Ronald H ^b   Basse, Per H ^b,d   Hokland, Marianne E ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MELANOMA; MICROVASCULATURE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMAL; FEMALE; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MICROSCOPY, ELECTRON; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SUPPORT, NON-U.S. GOV'T;

EID: 0028788455     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mazumder, A., and Rosenberg, S. A. Successful immunotherapy of natural killer resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2. J. Exp. Med., 159: 495–507, 1984.
2. Lafreniere, R., and Rosenberg, S. A. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. Cancer Res., 45: 3735–3741, 1985.
3. Mule, J. J., Shu, S., Schwarz, S. L., and Rosenberg, S. A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science (Washington DC), 225: 1487–1489, 1984.
4. Mule, J. J., Shu, S., and Rosenberg, S. A. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. J. Immunol., 135: 646–652, 1985.
5. Ettinghausen, S. E., Lipford, E., Mule, J. J., and Rosenberg, S. A. Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells. J. Immunol., 135: 3623–3635, 1985.
6. Schwarz, R. E., Vujanovic, N. L., and Hiserodt, J. C. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res., 49: 1441–1446, 1989.
7. Herberman, R. B., Basse, P., Jain, R. J., Melder, R. J., Goldfarb, R. H., Gorelik, E., Ernstoff, M. S., Kirkwood, J. M., and Whiteside, T. L. Approaches to immunotherapy with defined populations of IL-2 cultured NK cells, immune T cells or tumor infiltrating lymphocytes. In: R. C. Rees (ed.), The Biology and Clinical Applications of Interleukin-2, pp. 111–119. Oxford: Oxford University Press, 1990.
8. Vitolo, D., Vujanovic, N,. Rabinowich, H., Schlesinger, M., Herberman, R. B., and Whiteside, T. L. Rapid interleukin-2 induced adherence of human natural killer (NK) cells accompanied by expression of mRNA for cytokines and IL2 receptors. J. Immunol., 151: 1926–1937, 1993.
9. Basse, P., Herberman, R. B., Nannmark, U., Johansson, B. R., Hokland, M. E., Wasserman, K., and Goldfarb, R. H. Accumulation of adoptively transferred adherent lymphokine-activated killer cells in murine metastases. J. Exp. Med., 174: 479–488, 1991.
10. Basse, P., Nannmark, U., Johansson, B. R., Herberman, R. B., and Goldfarb, R. H. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J. Natl. Cancer Inst., 83: 944–950, 1991.
11. Kuppen, P. J. K., Basse, P. H., Goldfarb, R. H., van der Velde, C. J. H., Fleuren, G. J., and Eggermont, A. M. M. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2 activated natural killer cells in Wag rats. Int. J. Cancer, 56: 574–579, 1993.
12. Jonas, A. M., and Carrington, C. B. Vascular patterns in primary and secondary pulmonary tumors in the dog. Am. J. Pathol., 56: 79–95, 1969.
13. Shivas, A. A., and Gillespie, W. J. The vascularization of Brown-Pearce carcinoma implanted in the rabbit liver. Br. J. Cancer, 23: 638–643, 1969.
14. Gunji, Y., Vujanovic, N. L., Hiserodt, J. C., Herberman, R. B., and Gorelik, E. Generation and characterization of purified adherent lymphokine-activated killer cells in mice. Immunology, 142: 1748–1754, 1989.
15. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., and Mark, D. F. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science (Washington DC), 223: 1412–1414, 1984.
16. Wang, A., Lu, S. D., and Mark, D. F. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analyses of the cysteine residues. Science (Washington DC), 224: 1431–1433, 1984.
17. Basse, P. H., Herberman, R. B., Hokland, M. E., and Goldfarb, R. H. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol. Immunother., 34: 221–227, 1992.
18. Basse, P. H., Herberman, R. B., Hokland, M. E., and Goldfarb, R. H. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells: role of route of administration. Natl. Immunity Cell Growth Regul., 11: 193–202, 1992.
19. Milne, E. N. C., Noonan, C. D., Margulis, A. R., and Stoughton, J. A. Vascular supply of pulmonary metastases: experimental studies in rats. Invest. Radiol., 4: 215–229, 1969.
20. Alino, S. F., Rodeno, E., Simón, J., Garcia-Sanz, M., Alvares, F. J., and Hilario, E. Morpho-functional study of vascular fluorochrome delivery to lung and liver metastases of Lewis lung carcinoma (3LL). Tumori, 77: 206–211, 1991.
21. House, S. D., and Lipowsky, H. H. Leukocyte-endothelium adhesion: microhemo-dynamics in the mesentery of the cat. Microvasc. Res., 34: 363–379, 1987.
22. Milne, E. N. C., Margulis, A. R., Noonan, C. D., and Stoughton, J. A. Histologic type-specific vascular patterns in rat tumors. Cancer (Phila.), 20: 1635–1646, 1967.
23. Iwasaki, K., Kikuchi, H., Miyatake, S., Yamasaki, T., and Oda, Y. Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model. Cancer Res., 50: 2429–2436, 1990.
24. Jaaskelainen, J., Lehtonen, E., Heikkila, P. Kalliomaki, P., and Timonen, T. Damage to multicellular human H-2 glioma spheroids incubated with LAK cells: an ultra-structural study. J. Natl. Cancer Inst., 82: 497–501, 1990.
25. Sacchi, M., Vitolo, D., Sedlmayr, P., Rabinowich, H., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Induction of tumor regressions in experimental model of human head and neck cancer by human A-LAK cells and IL-2. Int. J. Cancer, 47: 784–791, 1991.